Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nice
Clinical trial register · France

Clinical Trials in Nice, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 46 Marseille 37 Toulouse 32 Bordeaux 29 Lille 23
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Centre Hospitalier Universitaire de Nice194 AbbVie32 Merck Sharp & Dohme LLC21 Novartis Pharmaceuticals20 Centre Antoine Lacassagne19 Clear sponsor filter
Site location
Paris46 Marseille37 Toulouse32 Bordeaux29 Lille23
All 72 locations
Target enrolment
to

Trials with a site in Nice

21 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 3
758
Nice, Marseille, Toulouse, Angers, Le Mans, Saint Priest En Jarez, Villejuif
2026-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Nice, Caen, Toulouse, Limoges, Vandœuvre-lès-Nancy, Reims, Angers, Rouen
2025-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 2
160
Nice, Paris, Villejuif
2025-05-29
Active, closed
Merck Sharp & Dohme LLC
Phase 2
440
Nice, Montpellier, Saint-Herblain, Angers, Rouen, Le Kremlin-Bicêtre
2025-04-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Nice, La Rochelle, Dijon, La Tronche, Limoges, Metz, Dunkirk, Clermont-Ferrand
2025-01-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,380
Nice, Neuilly-sur-Seine, Vandœuvre-lès-Nancy, Lille
2024-11-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Nice, Pessac, Marseille, Toulouse, Limoges, Tours, Nantes, Pierre-Bénite
2024-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Nice, Bayonne, Guilherand-Granges, Lyon Cedex08, Clermont-Ferrand, Marseille, Caen, Dijon
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Nice, Pessac, Marseille, Dijon, Reims, Besançon, Valence, Nîmes
2024-06-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Nice, Dijon, Nîmes, Valenciennes, Clermont-Ferrand, Avignon, Boulogne-Billancourt
2024-05-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Nice, Pessac, Marseille, Reims, Besançon, Nîmes, Clichy, Neuilly-sur-Seine
2023-10-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Nice, Marseille, Dijon, Besançon, Bordeaux, Rennes, Lille, Pierre-Bénite
2023-07-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
537
Nice, Tourcoing, Paris, Bobigny
2023-03-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
2,000
Nice, Dijon, Bordeaux, Toulouse, Rouen, Montpellier, Nantes, Tourcoing
2021-09-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
815
Nice, Pessac, Strasbourg, Brest, Toulouse, Lille, La Tronche, Saint-Herblain
2021-05-12
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Nice, Pierre-Bénite, Marseille, Le Chesnay, Paris
2021-04-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Reims, Nice, Strasbourg, Bordeaux, Toulouse, Limoges, Saint-Herblain, Angers
2021-02-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Vandœuvre-lès-Nancy, Nice, Caen, Plérin, Besançon, Bordeaux, Toulouse, Montpellier
2021-01-10
Active, closed
Merck Sharp & Dohme LLC
Phase 3
714
Nice, Marseille, Toulouse, Villejuif, Avignon, Paris
2018-12-17
Active, closed
Merck Sharp & Dohme LLC
Phase 2
329
Poitiers, Nice, Strasbourg, Dijon, Bordeaux, Villejuif
2018-12-12
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Nice, Strasbourg, Pessac, Pierre-Bénite, Lyon, Marseille, Caen, Dijon
2018-08-21
Rows per page Showing 1–21 of 21
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 October 2026. https://priyalifescience.com/clinical-trials-france/city/nice

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 21 of those studies with a site in Nice that also match the filters currently applied.

How many clinical trials are recruiting in Nice?

10 of the 21 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nice), 21 studies
PhaseStudiesRecruitingShare
Phase 317881%
Phase 24219%

Most active sponsors

Lead sponsors with the most studies (Nice)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC2110
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.